IQRx®: a valuable tool to fight rising pharmacy costs and reducing Adverse Drug Reaction risk.
Resolve Health’s intelligent prescribing solution, IQRx®, assists in identifying those are risk of adverse medication reaction while and proactively utilization pharmacogenomic profiles on a real time basis. The result is a return on investment by simply reducing pharmacy spend while also reducing the risks associated with Adverse Drug Reaction (ADR).
With 82% of American adults taking at least one drug and 29% of those adults taking five or more drugs, employers MUST ask themselves these questions:
Genetics can affect an individual’s response to medications both at home and while in the work place. Taking medications that are not the right fit for each person can not only increase the chances of unwanted side effects and lack of therapeutic benefit, but also will drive up pharmacy spend.
Some of medicines have more critical pharmacogenomic relevance and classified as safety-sensitive medications taken by those in safety-sensitive positions. Pharmacogenomic testing (PGT) is the study of how a person’s genetic makeup affects that individual’s response to medications. Combined with IQRx®, a person's pharmacogenomic profile develops a strategy to optimize drug therapies and maximize drug efficacy while minimizing adverse drug effects and drug-drug interactions.